CHRONIC SPONTANEOUS URTICARIA
Clinical trials for CHRONIC SPONTANEOUS URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First test of new hives drug in healthy people
Disease control CompletedThis early-stage study tested a new drug called LP-003 in healthy volunteers to see if it is safe and how the body processes it. The goal is to develop a treatment for chronic spontaneous urticaria, a condition causing long-lasting hives. Researchers gave single and multiple dose…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE1 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New pill tested to tame uncontrollable hives
Disease control CompletedThis study tested an oral medication called povorcitinib for adults with chronic spontaneous urticaria (long-lasting, unpredictable hives) that standard antihistamines could not control. The goal was to see if different doses of the drug could safely reduce hive and itch severity…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug tested for stubborn chronic hives
Disease control CompletedThis study tested a drug called remibrutinib in adults with chronic spontaneous urticaria (long-lasting hives) that standard antihistamines could not control. The main goal was to carefully check if the drug affected participants' blood pressure over 4 weeks, while also looking a…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New hope for kids with uncontrollable hives
Disease control CompletedThis study tested the drug dupilumab in children aged 2 to 12 with chronic spontaneous urticaria (CSU), a condition causing long-lasting, itchy hives. The goal was to see how the drug behaves in the body and check its safety in children whose hives were not controlled by standard…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New injection tested to tame Teenagers' unexplained hives
Disease control CompletedThis study tested an injectable drug called ligelizumab to see if it could better control chronic, unexplained hives in teenagers. It involved 49 adolescents aged 12 to 18 who still had bothersome hives despite taking standard allergy pills. Participants received either a high do…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for teens with uncontrollable hives
Disease control CompletedThis study looked at the safety and real-world effectiveness of an injectable medication called Xolair (omalizumab) for Chinese teenagers with chronic spontaneous urticaria (CSU), a condition causing persistent, itchy hives. It involved 55 adolescents whose hives were not adequat…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New injection tested for people whose hives Won't quit
Disease control CompletedThis study tested an investigational injection called LP-003 for adults with chronic spontaneous urticaria (CSU), a condition causing long-lasting, itchy hives. It was for people whose hives and itching were not controlled even with standard or higher doses of common antihistamin…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC